Disorders of anxiety and substance use are, for some reason, rarely treated in an integrated fashion by professionals. This timely volume addresses this glaring omission with dispatches from the frontlines of research and treatment. Thirty-four international experts offer findings, theories, and intervention strategies for this common form of dual disorder, across a range of substances and of anxiety disorders, to give the reader comprehensive knowledge in a practical format.
Cormorbity means the co-occurrence of one or more diseases or disorders in an individual. The National Comorbity Project aims to highlight this type of comorbity and identify appropriate strategies and policies responses.
Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.
This publication presents evidence about the magnitude and severe consequences of comorbidity of mental and physical illnesses from a personal and societal perspective. Leading experts address the huge burden of co-morbidity to the affected individual as well as the public health aspects, the costs to society and interaction with factors stemming from the context of socioeconomic developments. The authors discuss the clinical challenge of managing cardiovascular illnesses, cancer, infectious diseases and other physical illness when they occur with a range of mental and behavioral disorders, including substance abuse, eating disorders and anxiety. Also covered are the organization of health services, the training of different categories of health personnel and the multidisciplinary engagement necessary to prevent and manage comorbidity effectively. The book is essential reading for general practitioners, internists, public health specialists, psychiatrists, cardiologists, oncologists, medical educationalists and other health care professionals.
This book reviews the myriad of elements that layer substance abuse disorder, a significant public health issue. It addresses the strong stigma associated with the disease, particularly in regard to the doctor patient relationships. The book begins by explaining the importance of integrating psychiatric and substance use disorder treatment by demonstrating the efficacy of this treatment model. Subsequent to this are chapters dedicated to specific addiction disorders, including cocaine, opioids, gambling, food, and sex addictions. Chapters also examine how addiction can differ among various neurobiological, genetic, socioeconomic, and age demographics. The book closes with histories, policies, and modalities of drug use which serve as a key component to building a foundation for effective and ethical health policy. Written by international experts in addiction psychiatry, Substance and Non-Substance Related Addictions: A Global Approach is a valuable resource for all practitioners seeking to expand their knowledge of addiction medicine.
Trauma and Substance Abuse explores the underrecognized connection between trauma, substance use, and posttraumatic stress disorder (PTSD). Patients with trauma related distress such as PTSD often have comorbid substance use disorders (SUDs). This book presents cutting-edge research on how often the two disorders co-occur and why. Authors describe models of comorbidity and explore how specific PTSD and substance use symptoms are functionally related to each other. In addition, they suggest assessment approaches and practice guidelines to facilitate proper diagnosis and treatment. Particularly valuable are descriptions of several new treatment approaches that have been developed specifically for PTSD-SUD, including cognitive-behavioral and exposure therapy. This is the first book to evaluate and synthesize the two fields of PTSD and substance use disorder research and treatment. This volume is indispensable for researchers and clinicians seeking a full understanding of the etiology, assessment, and treatment of this challenging dual diagnosis.
Each year, more than 33 million Americans receive health care for mental or substance-use conditions, or both. Together, mental and substance-use illnesses are the leading cause of death and disability for women, the highest for men ages 15-44, and the second highest for all men. Effective treatments exist, but services are frequently fragmented and, as with general health care, there are barriers that prevent many from receiving these treatments as designed or at all. The consequences of this are seriousâ€"for these individuals and their families; their employers and the workforce; for the nation's economy; as well as the education, welfare, and justice systems. Improving the Quality of Health Care for Mental and Substance-Use Conditions examines the distinctive characteristics of health care for mental and substance-use conditions, including payment, benefit coverage, and regulatory issues, as well as health care organization and delivery issues. This new volume in the Quality Chasm series puts forth an agenda for improving the quality of this care based on this analysis. Patients and their families, primary health care providers, specialty mental health and substance-use treatment providers, health care organizations, health plans, purchasers of group health care, and all involved in health care for mental and substanceâ€"use conditions will benefit from this guide to achieving better care.
This book is a guide for psychologists working with substance users in different healthcare settings, from private clinical practice to larger health institutions and community services. It presents a comprehensive overview of the different aspects involved with substance use disorders from a psychological perspective, from prevention to recovery. The volume offers an integrative view about neurobiological, behavioral and psychosocial aspects related to becoming a substance user; shows how psychological assessment tools can be used to diagnose substance use disorders; describes how different kinds of psychotherapy can be applied in the treatment of substance use disorders; and presents a range of evidence-based clinical and social interventions designed for both prevention and treatment of substance use disorders. Apart from covering the whole range of services related to the prevention, diagnosis and treatment of substance use disorders, the volume also shows how these issues can be approached from different theoretical perspectives within psychology, such as: Behavioral and Cognitive Psychology Neuropsychology Existential Psychology Phenomenology Psychoanalysis Analytical Psychology Community and Social Psychology Psychology of Substance Abuse: Psychotherapy, Clinical Management and Social Intervention will be a useful resource for psychologists and other health professionals working with substance users, as well as to undergraduate and graduate students looking for a comprehensive introduction to the psychology of substance abuse.
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) is a cognitive-behavioral psychotherapy program designed for patients who have posttraumatic stress disorder (PTSD) and a co-occurring alcohol or drug use disorder. COPE represents an integration of two evidence-based treatments: Prolonged Exposure (PE) therapy for PTSD and Relapse Prevention for substance use disorders. COPE is an integrated treatment, meaning that both the PTSD and substance use disorder are addressed concurrently in therapy by the same clinician, and patients can experience substantial reductions in both PTSD symptoms and substance use severity. Patients use the COPE Patient Workbook while their clinician uses the Therapist Guide to deliver treatment. The program is comprised of 12 individual, 60 to 90 minute therapy sessions. The program includes several components: information about how PTSD symptoms and substance use interact with one another; information about the most common reactions to trauma; techniques to help the patient manage cravings and thoughts about using alcohol or drugs; coping skills to help the patient prevent relapse to substances; a breathing retraining relaxation exercise; and in vivo (real life) and imaginal exposures to target the patient's PTSD symptoms.
The essential newly-expanded reference that needs to be on the desk of every health care professional who encounters substance abusers. Handbook of the Medical Consequences of Alcohol and Drug Abuse, Second Edition is the newly-updated classic reference text that provides even more detailed and expanded information on the pharmacological, toxicological, and neuropsychological consequences of alcohol and drug abuse. Eight new chapters of crucial information have been added. Written by leading experts in the fields of medical physiology, psychopharmacology, and neuropsychology, this valuable resource provides the detailed alcohol and drug information health professionals in all fields need to know. Handbook of the Medical Consequences of Alcohol and Drug Abuse, Second Edition greatly expands on the expert information provided in the first edition. This text provides reviews of the cardiovascular, neurological, pulmonary, gastrointestinal, psychological, and hepatic effects of commonly abused drugs. The book also provides in-depth explanations of the mechanisms by which these psychoactive drugs exert their biobehavioral effects as well as current thinking about—and definitions of—abuse, dependence, and alcohol/drug use. The Handbook of the Medical Consequences of Alcohol and Drug Abuse, Second Edition includes vital information on: alcohol, including definitions of alcohol use, abuse, and dependence the relationship between alcohol and accidental injuries, alcohol’s effect on skeletal and major organ systems, and its effect on risk factors for certain cancers effects of alcohol and other drugs on neuropsychological function the effects of alcohol on neuron signaling, neurotransmitter function, and alcoholic brain damage and cognitive dysfunction fetal alcohol effects chronic effects of marijuana use on psychological and physical health, including a fair and balanced discussion of the medical marijuana issue the consequences of opiate abuse and methadone pharmacotherapy, including a comparison of the effects of methadone and heroin on organ systems cocaine’s history, the various forms of the drug, and the adverse effects of cocaine on cardiovascular, neurologic, and pulmonary systems the medical consequences of inhalants ranging from benzene to xylene the prenatal effects of nicotine, cocaine, marijuana, and opiates terminology that appears in the current literature on alcohol New topics in the Handbook of the Medical Consequences of Alcohol and Drug Abuse, Second Edition include chapters discussing: chemical dependency in psychiatric patients medical consequences of steroids OTC medications hallucinogens health effects of tobacco, nicotine, and exposure to tobacco smoke interactions of alcohol with other drugs and other medications periodontal effects of alcohol and drug abuse in the oral cavity imaging studies of structural brain changes The Handbook of the Medical Consequences of Alcohol and Drug Abuse, Second Edition is an invaluable resource for physicians, scientists, nurses, psychologists, and alcohol and drug counselors.
